Remove 2023 Remove Clinical Trials Remove Medical Evaluation
article thumbnail

Microdosing Cannabis in Miami: What It Is and How It Might Help

LifeCannMD

A 2023 study in Cannabis and Cannabinoid Research validated this approach, showing that patients following slower titration schedules had 84% treatment satisfaction compared to 61% with faster increases. The Stanford Sleep Laboratory Findings Stanford’s Sleep Research Center studied 847 insomnia patients using different cannabis doses.

article thumbnail

DEA Pushes Marijuana Rescheduling Hearing To December: What Does This Mean For Cannabis?

Veriheal

Not only would medicinal cannabis-derived products become more legally available for patients’ use, but a successful rescheduling would also open increased opportunities for new clinical trials, helping to further the advancement of therapeutic options available. drug policy and public opinion regarding cannabis’ status as a medicine.

DEA